Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
07 2020
Historique:
received: 04 06 2019
accepted: 04 10 2019
pubmed: 12 10 2019
medline: 28 4 2021
entrez: 12 10 2019
Statut: ppublish

Résumé

Uric acid is a danger signal contributing to inflammation. Its relevance to allogeneic stem cell transplantation (alloSCT) derives from preclinical models where the depletion of uric acid led to improved survival and reduced graft-

Identifiants

pubmed: 31601686
pii: haematol.2019.228668
doi: 10.3324/haematol.2019.228668
pmc: PMC7327652
doi:

Substances chimiques

Uric Acid 268B43MJ25

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1977-1983

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

Sci Rep. 2017 Jan 13;7:39884
pubmed: 28084303
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
Bone Marrow Transplant. 1992 Oct;10(4):337-9
pubmed: 1422489
N Engl J Med. 2016 Jan 7;374(1):43-53
pubmed: 26735993
PLoS One. 2018 Dec 14;13(12):e0209156
pubmed: 30550582
Biol Blood Marrow Transplant. 2003 Apr;9(4):215-33
pubmed: 12720215
Biol Blood Marrow Transplant. 2014 May;20(5):730-4
pubmed: 24530972
J Exp Med. 2013 Sep 23;210(10):1899-910
pubmed: 23980097
Clin Lab. 2018 Sep 1;64(9):1491-1500
pubmed: 30274009
Front Immunol. 2016 Oct 21;7:439
pubmed: 27818661
Nature. 2006 Mar 9;440(7081):237-41
pubmed: 16407889
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076
Ann Hematol. 2015 Jan;94(1):139-44
pubmed: 25172456
J Heart Lung Transplant. 2018 Sep;37(9):1083-1092
pubmed: 29802086
J Cancer Res Clin Oncol. 2017 May;143(5):759-771
pubmed: 28210842
J Intensive Care Med. 2019 May;34(5):404-410
pubmed: 28351229
Blood Res. 2016 Sep;51(3):200-203
pubmed: 27722132

Auteurs

Olaf Penack (O)

Charité Universitätsmedizin Berlin, Berlin, Germany.

Christophe Peczynski (C)

EBMT Statistical Unit, Paris, France.

Steffie van der Werf (S)

EBMT Data Office, Leiden, the Netherlands.

Jürgen Finke (J)

University of Freiburg, Freiburg, Germany.

Arnold Ganser (A)

Hannover Medical School, Hannover, Germany.

Helene Schoemans (H)

Department of Hematology, University Hospital Leuven and KU Leuven, Leuven, Belgium.

Jiri Pavlu (J)

Imperial College, London, UK.

Riitta Niittyvuopio (R)

HUCH Comprehensive Cancer Center, Helsinki, Finland.

Wilfried Schroyens (W)

Antwerp University Hospital, Antwerp, Belgium.

Leylagül Kaynar (L)

Erciyes University Medical Faculty, Kayseri, Turkey.

Igor W Blau (IW)

Charité Universitätsmedizin Berlin, Berlin, Germany.

Walter van der Velden (W)

Radboud University - Nijmegen Medical Centre, Nijmegen, the Netherlands.

Jorge Sierra (J)

Hospital Santa Creu I Sant Pau, Barcelona, Spain.

Agostino Cortelezzi (A)

Fondazione IRCCS - Ca'Granda, Milan, Italy.

Gerald Wulf (G)

Universitätsklinikum Göttingen, Göttingen, Germany.

Pascal Turlure (P)

CHRU Limoges, Limoges, France.

Montserat Rovira (M)

Hospital Clinic, Barcelona, Spain.

Zubeydenur Ozkurt (Z)

Gazi University Faculty of Medicine, Ankara, Turkey.

Maria J Pascual-Cascon (MJ)

Hospital Regional de Málaga, Malaga, Spain.

Maria C Moreira (MC)

Instituto National do Cancer, Rio de Janeiro, Brazil.

Johannes Clausen (J)

Elisabethinen-Hospital, Linz, Austria.

Hildegard Greinix (H)

LKH - University Hospital Graz, Graz, Austria.

Rafael F Duarte (RF)

Hospital Universitario Puerta de Hierro, Madrid, Spain.

Grzegorz W Basak (GW)

Medical University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH